Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2016, Article ID 2710858, 8 pages
http://dx.doi.org/10.1155/2016/2710858
Research Article

Improved Biocompatibility of Novel Biodegradable Scaffold Composed of Poly-L-lactic Acid and Amorphous Calcium Phosphate Nanoparticles in Porcine Coronary Artery

1Institute of Comparative Medicine and Animal Center, Southern Medical University, Guangzhou 510282, China
2Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China
3Department of Cardiology, The Affiliated Dongguan Hospital, Jinan University School of Medicine (The Fifth Renmin Hospital of Dongguan), Dongguan 523000, China
4VasoTech, Inc., 600 Suffolk Street, Lowell, MA 01854, USA
5Dongguan TT Medical, Inc., Dongguan 523808, China
6Emergency & Critical Care Center, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China

Received 4 December 2015; Accepted 28 February 2016

Academic Editor: Newton M. Barbosa-Neto

Copyright © 2016 Dongsheng Gu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Mehran, G. Dangas, A. S. Abizaid et al., “Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome,” Circulation, vol. 100, no. 18, pp. 1872–1878, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. J. E. Sousa, M. A. Costa, A. Abizaid et al., “Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study,” Circulation, vol. 107, no. 1, pp. 24–27, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Joner, A. V. Finn, A. Farb et al., “Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk,” Journal of the American College of Cardiology, vol. 48, no. 1, pp. 193–202, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Hoffmann and G. S. Mintz, “Coronary in-stent restenosis—predictors, treatment and prevention,” European Heart Journal, vol. 21, no. 21, pp. 1739–1749, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. A. V. Finn, G. Nakazawa, M. Joner et al., “Vascular responses to drug eluting stents: importance of delayed healing,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 7, pp. 1500–1510, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Nakazawa, E. Ladich, A. V. Finn, and R. Virmani, “Pathophysiology of vascular healing and stent mediated arterial injury,” EuroIntervention, vol. 4, supplement C, pp. C7–C10, 2008. View at Google Scholar · View at Scopus
  7. F. Prati, M. Zimarino, E. Stabile et al., “Does optical coherence tomography identify arterial healing after stenting? An in vivo comparison with histology, in a rabbit carotid model,” Heart, vol. 94, no. 2, pp. 217–221, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. Sun, “Endovascular stents and stent grafts in the treatment of cardiovascular disease,” Journal of Biomedical Nanotechnology, vol. 10, no. 10, pp. 2424–2463, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. Lan, Y. Lyu, J. Xiao et al., “Novel biodegradable drug-eluting stent composed of poly-L-lactic acid and amorphous calcium phosphate nanoparticles demonstrates improved structural and functional performance for coronary artery disease,” Journal of Biomedical Nanotechnology, vol. 10, no. 7, pp. 1194–1204, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. X. Zheng, Y. Wang, Z. Lan et al., “Improved biocompatibility of poly(lactic-co-glycolic acid) and poly-L-lactic acid blended with nanoparticulate amorphous calcium phosphate in vascular stent applications,” Journal of Biomedical Nanotechnology, vol. 10, no. 6, pp. 900–910, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Vogt, A. Stein, G. Rettemeier et al., “Long-term assessment of a novel biodegradable paclitaxel-eluting coronary polylactide stent,” European Heart Journal, vol. 25, no. 15, pp. 1330–1340, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. W. J. Van der Giessen, A. M. Lincoff, R. S. Schwartz et al., “Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries,” Circulation, vol. 94, no. 7, pp. 1690–1697, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Qiu, X.-Y. Hu, T. Luo et al., “Short-term safety and effects of a novel fully bioabsorable poly-L-lactic acid sirolimus-eluting stents in porcine coronary arteries,” Chinese Medical Journal, vol. 126, no. 6, pp. 1183–1185, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. A. M. Lincoff, J. G. Furst, S. G. Ellis, R. J. Tuch, and E. J. Topol, “Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model,” Journal of the American College of Cardiology, vol. 29, no. 4, pp. 808–816, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Busch, A. Strohbach, S. Rethfeldt et al., “New stent surface materials: the impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets,” Acta Biomaterialia, vol. 10, no. 2, pp. 688–700, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Kipshidze, G. Dangas, M. Tsapenko et al., “Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions,” Journal of the American College of Cardiology, vol. 44, no. 4, pp. 733–739, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Combes and C. Rey, “Amorphous calcium phosphates: synthesis, properties and uses in biomaterials,” Acta Biomaterialia, vol. 6, no. 9, pp. 3362–3378, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Skrtic, J. M. Antonucci, and E. D. Eanes, “Improved properties of amorphous calcium phosphate fillers in remineralizing resin composites,” Dental Materials, vol. 12, no. 5-6, pp. 295–301, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Tamai, K. Igaki, E. Kyo et al., “Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans,” Circulation, vol. 102, no. 4, pp. 399–404, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Waksman, “Promise and challenges of bioabsorbable stents,” Catheterization and Cardiovascular Interventions, vol. 70, no. 3, pp. 407–414, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Engineer, J. Parikh, and A. Raval, “Effect of copolymer ratio on hydrolytic degradation of poly(lactide-co-glycolide) from drug eluting coronary stents,” Chemical Engineering Research and Design, vol. 89, no. 3, pp. 328–334, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Flege, F. Vogt, S. Höges et al., “Development and characterization of a coronary polylactic acid stent prototype generated by selective laser melting,” Journal of Materials Science: Materials in Medicine, vol. 24, no. 1, pp. 241–255, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Jabara, N. Chronos, O. Hnojewyj, P. Rivelli, and K. Robinson, “Initial assessment of a novel anti-inflammatory bioabsorbable salicylate-based polymer eluting sirolimus for use in fully bioabsorbable coronary stents,” Cardiovascular Revascularization Medicine, vol. 8, no. 2, pp. 131–132, 2007. View at Publisher · View at Google Scholar
  24. D. F. Williams, “On the mechanisms of biocompatibility,” Biomaterials, vol. 29, no. 20, pp. 2941–2953, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. T. D. Gilmore, “Introduction to NF-κB: players, pathways, perspectives,” Oncogene, vol. 25, no. 51, pp. 6680–6684, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Monaco, E. Andreakos, S. Kiriakidis et al., “Canonical pathway of nuclear factor κB activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 15, pp. 5634–5639, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. J. H. Southerland, G. W. Taylor, K. Moss, J. D. Beck, and S. Offenbacher, “Commonality in chronic inflammatory diseases: periodontitis, diabetes, and coronary artery disease,” Periodontology 2000, vol. 40, no. 1, pp. 130–143, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. N. S. Rial, K. Choi, T. Nguyen, B. Snyder, and M. J. Slepian, “Nuclear factor kappa B (NF-κB): a novel cause for diabetes, coronary artery disease and cancer initiation and promotion?” Medical Hypotheses, vol. 78, no. 1, pp. 29–32, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. A. V. Finn, M. Joner, G. Nakazawa et al., “Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization,” Circulation, vol. 115, no. 18, pp. 2435–2441, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Curcio, D. Torella, and C. Indolfi, “Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy,” Circulation Journal, vol. 75, no. 6, pp. 1287–1296, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. P. C. Evans, E. R. Taylor, and P. J. Kilshaw, “Signaling through CD31 protects endothelial cells from apoptosis,” Transplantation, vol. 71, no. 3, pp. 457–460, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Choi, M. Kennedy, A. Kazarov, J. C. Papadimitriou, and G. Keller, “A common precursor for hematopoietic and endothelial cells,” Development, vol. 125, no. 4, pp. 725–732, 1998. View at Google Scholar · View at Scopus
  33. S. M. Albelda, W. A. Muller, C. A. Buck, and P. J. Newman, “Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule,” Journal of Cell Biology, vol. 114, no. 5, pp. 1059–1068, 1991. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Lamas, P. A. Marsden, G. K. Li, P. Tempst, and T. Michel, “Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 14, pp. 6348–6352, 1992. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Wang and P. A. Marsden, “Nitric oxide synthases: biochemical and molecular regulation,” Current Opinion in Nephrology and Hypertension, vol. 4, no. 1, pp. 12–22, 1995. View at Publisher · View at Google Scholar
  36. X. F. Figueroa, D. R. González, M. Puebla et al., “Coordinated endothelial nitric oxide synthase activation by translocation and phosphorylation determines flow-induced nitric oxide production in resistance vessels,” Journal of Vascular Research, vol. 50, no. 6, pp. 498–511, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Ferrara, “Vascular endothelial growth factor,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 6, pp. 789–791, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Bry, R. Kivelä, V.-M. Leppänen, and K. Alitalo, “Vascular endothelial growth factor-B in physiology and disease,” Physiological Reviews, vol. 94, no. 3, pp. 779–794, 2014. View at Publisher · View at Google Scholar · View at Scopus